Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes

Original Article

C.P. Cannon, R. Pratley, S. Dagogo-Jack, J. Mancuso, S. Huyck, U. Masiukiewicz, B. Charbonnel, R. Frederich, S. Gallo, F. Cosentino, W.J. Shih, I. Gantz, S.G. Terra, D.Z. Cherney, and D.K. McGuire

N Engl J Med 2020;383:1425-1435

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
10/07/2020
Course expires: 
10/08/2022

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Saturday, October 8, 2022 - 11:59pm.